mEH Antibodies

Santa Cruz Biotechnology features a diverse variety of mEH Antibodies for advanced research in molecular biology. mEH Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). mEH, or microsomal epoxide hydrolase, plays a crucial role in the metabolism of xenobiotics and endogenous compounds by converting epoxides into less toxic diols. Microsomal epoxide hydrolase is essential for detoxification processes and has significant implications in drug metabolism, as well as in the development of certain diseases. Understanding microsomal epoxide hydrolase function is vital for researchers studying pharmacology, toxicology, and disease mechanisms. mEH Antibodies targeting mEH enable precise detection and characterization of this enzyme across various experimental conditions. Research utilizing mEH monoclonal antibodies from Santa Cruz Biotechnology continues to advance our understanding of drug metabolism and disease pathways, supporting scientific discoveries worldwide.